{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:30:00Z","timestamp":1789435800838,"version":"build-2803163510"},"reference-count":36,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,4,24]],"date-time":"2007-04-24T00:00:00Z","timestamp":1177372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2007,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>We report outcomes after myeloablative haematopoietic cell transplantation (HCT) from human leucocyte antigen (HLA)\u2010matched sibling donors in 67 patients with sickle cell disease transplanted between 1989 and 2002. The most common indications for transplantation were stroke and recurrent vaso\u2010occlusive crisis in 38% and 37% of patients respectively. The median age at transplantation was 10\u2003years and 67% of patients had received &gt;10 red blood cell transfusions before HCT. Twenty\u2010seven percent of patients had a poor performance score at transplantation. Ninety\u2010four percent received busulfan and cyclophosphamide\u2010containing conditioning regimens and bone marrow was the predominant source of donor cells. Most patients achieved haematopoietic recovery and no deaths occurred during the early post\u2010transplant period. Rates of acute and chronic graft\u2010versus\u2010host disease were 10% and 22% respectively. Sixty\u2010four of 67 patients are alive with 5\u2010year probabilities of disease\u2010free and overall survival of 85% and 97% respectively. Nine patients had graft failure with recovery of sickle erythropoiesis, eight of who had recurrent sickle\u2010related events. This report confirms and extends earlier reports that HCT from HLA\u2010matched related donors offers a very high survival rate, with few transplant\u2010related complications and the elimination of sickle\u2010related complications in the majority of patients who undergo this therapy.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2007.06592.x","type":"journal-article","created":{"date-parts":[[2007,5,6]],"date-time":"2007-05-06T03:51:59Z","timestamp":1178423519000},"page":"479-485","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":142,"title":["Matched\u2010related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research"],"prefix":"10.1111","volume":"137","author":[{"given":"Julie A.","family":"Panepinto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Carreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher N.","family":"Bredeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Peter","family":"Gale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Hale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Horan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill M.","family":"Hows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Pasquini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Eapen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Ferster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the Non\u2010Malignant Marrow Disorders Working Committee, Center for International Blood and Marrow Transplant Research","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,5]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050460"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-104-4-461"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.97.6.864"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V75.12.2459.2459"},{"key":"e_1_2_6_6_1","first-page":"59","article-title":"Results and current indications of bone marrow allograft in sickle cell disease","volume":"47","author":"Bernaudin F.","year":"1999","journal-title":"Pathologie-Biologie (Paris)"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/002221949302600104"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpepsy\/25.7.503"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.6.1678"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1992.tb06407.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004703-198808000-00006"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035477"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1083-8791(03)00192-7"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20169"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05667.x"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.103.3.640"},{"key":"e_1_2_6_17_1","doi-asserted-by":"crossref","DOI":"10.1007\/b97377","volume-title":"Survival Analysis: Techniques of Censored and Truncated Data","author":"Klein J.P.","year":"2003"},{"key":"e_1_2_6_18_1","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene\u2010Frempong K.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199107043250103"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406093302303"},{"key":"e_1_2_6_21_1","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka D.","year":"1995","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2005.12.055"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.8.1109"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10727"},{"key":"e_1_2_6_25_1","first-page":"382","article-title":"Cognitive impairment in children with hemoglobin SS sickle cell disease: relationship to MR imaging findings and hematocrit","volume":"24","author":"Steen R.G.","year":"2003","journal-title":"AJNR American Journal of Neuroradiology"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-92-1-30"},{"key":"e_1_2_6_27_1","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1182\/blood.V92.8.2742","article-title":"Decreased rejection and improved survival of first and second marrow transplants for severe aplastic anemia (a 26\u2010year retrospective analysis)","volume":"92","author":"Stucki A.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mph.0000194022.17968.bf"},{"key":"e_1_2_6_29_1","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1542\/peds.84.6.1077","article-title":"Neuropsychologic impairment in children with sickle cell anemia","volume":"84","author":"Swift A.V.","year":"1989","journal-title":"Pediatrics"},{"key":"e_1_2_6_30_1","first-page":"18","article-title":"Bone marrow transplantation for sickle cell disease. The European experience","volume":"16","author":"Vermylen C.","year":"1994","journal-title":"American Journal of Pediatric Hematology and Oncology"},{"issue":"1","key":"e_1_2_6_31_1","first-page":"116","article-title":"Bone marrow transplantation in sickle cell disease: the Belgian experience","volume":"12","author":"Vermylen C.","year":"1993","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701291"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-2265.2004.00188.x"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199608083350601"},{"key":"e_1_2_6_35_1","first-page":"310","article-title":"Collaborative multicenter investigation of marrow transplantation for sickle cell disease: current results and future directions","volume":"3","author":"Walters M.C.","year":"1997","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"e_1_2_6_36_1","first-page":"1918","article-title":"Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease","volume":"95","author":"Walters M.C.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1053\/bbmt.2001.v7.pm11787529"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2007.06592.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2007.06592.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T15:28:16Z","timestamp":1697383696000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2007.06592.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["10.1111\/j.1365-2141.2007.06592.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2007.06592.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5]]},"assertion":[{"value":"2007-05-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}